Table: Aska Pharmaceutical -9-MTH group results

ASKA Pharmaceutical Holdings

06/02/2017 06:00

Feb 6 (Reuters)-  
             Aska Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended       Year to  
                Dec 31, 2016        Dec 31, 2015     Mar 31, 2017  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             37.48               33.53            48.00     
                 (+11.8 pct)         (-0.6 pct)       (+11.1 pct)  
  Operating          1.98                1.64             1.80     
                 (+20.3 pct)         (-13.3 pct)      (+40.3 pct)  
  Recurring          2.20                1.84             2.00     
                 (+19.5 pct)         (-13.0 pct)      (+31.4 pct)  
  Net                3.91                1.08             3.60     
                (+262.0 pct)         (-27.1 pct)     (+413.6 pct)  
  EPS            139.99 yen           38.75 yen       128.85 yen   
  Ann Div                             14.00 yen        14.00 yen   
  -Q2 div         7.00 yen            7.00 yen                     
  -Q4 div                             7.00 yen         7.00 yen    
   
  NOTE - Aska Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T 
  ((Tokyo Headline News Desk +813 6441 1812))